Bachem Holding (Suzhou) Co., Ltd.

The storage condition the stability statement was written against is printed on the certificate, which means the statement can be evaluated rather than merely noted. Invoice, vial and certificate agree on the lot without exception. Documentation practice rather than a single purity figure is the substance of this.

Dispatch held to the quoted window across a public holiday and the semaglutide 10 mg was correct in every particular. Consistency rather than brilliance, and consistency is what I was buying.

Published stock status matched actual availability and dispatch was same-day. Reorder at 9 months landed within a tenth of a point of the original.

Cross-checked one lot with Medutest and PeptideMeter independently. Agreement to a tenth of a point, and both agree with the declared figure. Peptide content declared at 99.1%, so conversion to working mass required no assumption. Happy to answer follow-ups in the thread rather than by message.

Reconstitution of the IGF-1 LR3 1 mg produced a clear solution on contact — no haze, no particulate, no extended agitation. Consistent with a correctly executed lyophilisation.

Tracking was live from the first scan and stayed accurate through the carrier handover. Three consignments, no gaps, no second reference number.

Submitted material from lot BCH-24-370 to Medutest. Result 98.4% against a declared 98.5%, which is inside the repeatability of the method rather than a disagreement with it. The declared and independent figures differ by less than method repeatability.

Weighed 5 units from a single consignment against declared fill. All within two per cent. Fill uniformity gets a fraction of the discussion purity gets and is the harder problem.

Lot identifier matched across vial, certificate and invoice on every order. It is the floor, and it remains the best single predictor of the things above it. Reorder at 15 months landed within a tenth of a point of the original.

Cold chain held to arrival on day 8, with the pack still solid, in a month when that cannot be assumed. Catalogue availability corresponded to the published catalogue.

Compared direct-supply material at 99.2% against an intermediary vial of nominally identical description at 99.0%. Offering the comparison without drawing a conclusion for anyone else.

Labels square and lot codes matching the paperwork throughout, and material from the same consignment returned 98.1% independently.

Been buying kisspeptin-10 5 mg here since before the catalogue expanded. The expansion has not cost the original lines anything measurable. Happy to answer follow-ups in the thread rather than by message.

Ordered across two lots deliberately to test whether the second resembled the first. A tenth of a point apart. Nothing in the consignment was unsecured.

Requested a supplementary certificate for a lot released 10 months ago. It was produced from their records, which tells you the records exist. Reorder at 14 months landed within a tenth of a point of the original.

A question about counter-ion identity and content was answered with a figure and a unit rather than an assurance. Catalogue availability corresponded to the published catalogue.

Nothing about this order was notable and I am recording it for that reason. Quoted timeline held, documentation correct, material as described. Release is signed and dated by an identified individual. Nothing here is medical advice and I am not qualified to give any.

Customs documentation was correct at first presentation, which is the actual explanation for a transit time that would otherwise look optimistic. Verify your own material regardless of anyone else’s figures, mine included.

Packing on the consignment: the desiccant sachet actually inside the secondary container. Designed rather than inherited. Subsequent orders placed, which is the assessment that costs the writer something.

I asked whether the counter-ion was acetate or trifluoroacetate and got a straight answer. Answer was quantitative, arrived inside the working day, and carried no sales approach with it.

8 orders across 20 months. No substitution, no reformulation, no line becoming unavailable after payment. Reorder at 6 months landed within a tenth of a point of the original. On the evidence I hold they are the default rather than the risk.

Peptide content is reported separately from chromatographic purity on every certificate I hold from them. Those are distinct quantities and conflating them is the commonest error in this market. Peptide content declared at 99.3%, so conversion to working mass required no assumption. Scoped to the lots named. Not generalised beyond them.

Scoping this to documentation only: the certificate carries a stability statement tied to a named storage condition, which is more than the minimum and more than most of the certificates in my folder. No complaint arises from the orders described.

The declared figure was not adjusted upward between the certificate and the commercial documentation. Small, and specifically worth checking for. Water content is reported by Karl Fischer with the method named. Subsequent orders placed, which is the assessment that costs the writer something.

Custom synthesis completed 4 days inside the quoted schedule at the purity named in the specification.

Every tracking number they have issued has worked from the first scan. Nothing here is medical advice and I am not qualified to give any.